EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 22-Jun-2026 16:16 ET (22-Jun-2026 20:16 GMT/UTC)

Insilico and TaiGen achieve milestone in collaboration: Out-licensed CKD anemia candidate ISM4808 completes first human enrollment and dosing in Phase I clinical trial

InSilico Medicine
Business Announcement

CAMBRIDGE, Mass., — Insilico Medicine (Insilico Medicine, HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced that ISM4808, an AI-driven PHD inhibitor for chronic kidney disease (CKD)-related anemia previously out-licensed to TaiGen Biotechnology (TaiGen*-KY, 4157), has achieved its first milestone. Recently, TaiGen has successfully completed the enrollment and dosing of the first subject in the Phase I clinical trial.

GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death

BMJ Group
Peer-Reviewed Publication

Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of substances including alcohol, cannabis, cocaine, nicotine, and opioids, finds a large US study published by The BMJ today.

Journal: The BMJ
Funder: United States Department of Veterans Affairs

Councils face industry legal threats for campaigns warning against wood burning stoves

BMJ Group
Peer-Reviewed Publication

As the UK government considers adding health warnings to new wood burning stoves, as part of a public consultation on solid fuel burning, councils in England are being threatened with legal action for running public health campaigns warning against their use, reveals an investigation published by The BMJ today.

Journal: The BMJ
Funder: BMJ Investigations Unit, Impact on Urban Health

GLP-1 medications get at the heart of addiction: study

WashU Medicine
Peer-Reviewed Publication

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major addictive substances studied, suggesting these drugs target a common biological pathway underlying addiction.

Journal: BMJ
Funder: U.S. Department of Veterans Affairs

Global trauma study highlights shared learning as interest in whole blood resurges

University of Cambridge
Peer-Reviewed Publication

A new international study published in The Lancet eClinicalMedicine has mapped global blood transfusion practices for life-threatening abdominal injuries, highlighting significant variation in care worldwide and opportunities for health systems to learn from one another.

Journal: EClinicalMedicine

How much sleep do teens get? Six-seven hours.

University of Connecticut
Peer-Reviewed Publication

Teenagers across the country are getting less sleep, a researcher from the University of Connecticut reports on March 2 in JAMA. And the problem appears to be societal.

Journal: JAMA

First gene regulation clinical trials for epilepsy show promising results

Ann & Robert H. Lurie Children's Hospital of Chicago
Peer-Reviewed Publication

Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children’s Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and well tolerated by patients with Dravet syndrome for whom antiseizure medications are not effective. Results, published in the New England Journal of Medicine, include significant seizure reduction and improvement in other symptoms of Dravet syndrome, such as language, motor and behavior issues. Researchers also report sustained treatment benefits in ongoing open-label extension studies.

Journal: New England Journal of Medicine

Life-changing drug identified for children with rare epilepsy

University College London
Peer-Reviewed Publication

A new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, helping them lead much healthier and happier lives, the findings of a UCL (University College London) and Great Ormond Street Hospital-led international clinical trial show.

Journal: New England Journal of Medicine

Machine-learning immune-system analysis study may hold clues to personalized medicine

York University
Peer-Reviewed Publication

A new study led by York University found that not only could machine-learning models accurately pinpoint differences in healthy controls and those living with HIV, but also found outliers in both groups that provide fascinating glimpses into the complex nature of the immune system and what personalized medicine could look like in the future, accounting for variables such as age, comorbidities and genetics.

Journal: Patterns